You are searching for: hsa04917

---

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T87166 Target Info	Target Name	Glucokinase (GCK)
	Target type	Clinical trial Target
	Disease	Type 2 diabetes; Type-1 diabetes;
	Drugs	TTP399	Drug Info

T71266 Target Info	Target Name	RAC-gamma serine/threonine-protein kinase (AKT3)
	Target type	Successful Target
	Disease	Breast cancer; Triple negative breast cancer;
	Drugs	Capivasertib	Drug Info

T65864 Target Info	Target Name	Stress-activated protein kinase 2a (p38 alpha)
	Target type	Clinical trial Target
	Disease	Xerophthalmia; Acute coronary syndrome;
	Drugs	Ozagrel	Drug Info

T55729 Target Info	Target Name	Stress-activated protein kinase 2b (p38 beta)
	Target type	Clinical trial Target
	Disease	Alzheimer disease; Rheumatoid arthritis;
	Drugs	VX-745	Drug Info

T40097 Target Info	Target Name	Stress-activated protein kinase JNK1 (JNK1)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer; T-cell leukaemia;
	Drugs	NKP-1339	Drug Info

T05031 Target Info	Target Name	PI3-kinase beta (PIK3CB)
	Target type	Clinical trial Target
	Disease	Breast cancer; Squamous head and neck cell carcinom;
	Drugs	Buparlisib	Drug Info

T23276 Target Info	Target Name	Extracellular signal-regulated kinase 1 (ERK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T12355 Target Info	Target Name	G1/S-specific cyclin-D1 (CCND1)
	Target type	Clinical trial Target
	Disease	Myelofibrosis; Relapsed or refractory chronic lymphocytic leukaemia;
	Drugs	ABT-263	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.